Table 3.
Analysis | Variable | Prospective Cohort (N = 296) | Retrospective Cohort (N = 116) | ||||
---|---|---|---|---|---|---|---|
HR (95% CI) | P value | C-index (95% CI) | HR (95% CI) | P value | C-index (95% CI) | ||
A. Previous Models | |||||||
Model 1 | 3p &/or 9p LOH† | 22·6 (3·1-164·5) | 0·002 | 0·66 (0·47, 0·81) | 21.1 (2·9-155·8) | 0·003 | 0·70 (0·48, 0·86) |
Model 2 | 3p &/or 9p LOH | 18·5 (2·5-135·3) | 0·004 | 14·4 (1·9-111·7) | 0·01 | ||
High-risk site | 2·5 (1·2-5·6) | 0·02 | 0·75 (0·56, 0·87) | 1·9 (0·8-4·7) | 0·16 | 0·77 (0·53, 0·91) | |
Non-smoker | 1·8 (1·0-3·4) | 0·06 | 1·8 (0·8-4·2) | 0·17 | |||
B. Current Models | |||||||
Model 3 | Intm-risk LOH* | 11·6 (2·7-49·9) | 0·001 | 0·79 (0·59, 0·91) | 3·4 (1·4-8·2) | 0·006 | 0·68 (0·46, 0·84) |
High-risk LOH‡ | 52·1 (11·8-230·6) | <0·001 | 11·2 (3·3-38·6) | <0·001 | |||
Model 4 | Intm-risk LOH* | 9·7 (2·2-42·0) | 0·003 | 3·2 (1·1-9·4) | 0·04 | ||
High-risk LOH‡ | 41·7 (9·3-187·6) | <0·001 | 0·81 (0·61, 0·92) | 7·6 (1·8-32·6) | 0·007 | 0·75 (0·51, 0·90) | |
High-risk site | 1·8 (0·8-4·0) | 0·16 | 2·2 (0·8-5·7) | 0·12 | |||
Non-smoker | 2·0 (1·0-3·8) | 0·05 | 1·7 (0·7-4·1) | 0·21 |
High-risk LOH: (3p &/or 9p LOH) compared to Low-Risk (3p and 9p R).
Intm-R (Intermediate-risk LOH): (9pLOH only or with either 17pLOH or 4qLOH but not both) compared to Low-Risk (9pR).
High-risk LOH: (9pL and 4qL and 17pL).